CSIMarket
 


Frequency Therapeutics Inc   (FREQ)
Other Ticker:  
 

Frequency Therapeutics Inc 's Long Term Debt to Equity

FREQ's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




FREQ Long Term Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -44.28 % -42.27 % -36.49 % -32.04 % -26.29 %
Y / Y Long Term Debt Change -55.55 % -38.89 % -22.22 % -5.55 % -
Long Term Debt to Equity MRQ 0.08 0.1 0.1 0.11 0.1
Overall Ranking # # # # #
Seq. Equity Change -14.48 % -14.93 % -13.88 % -11.07 % -11.4 %
Seq. Long Term Debt Change -27.27 % -21.43 % -17.65 % -5.55 % 0 %



Long Term Debt to Equity third quarter 2022 Comment
Due to long-term debt repayement of -27.27% Frequency Therapeutics Inc improved Long Term Debt to Equity in third quarter 2022 to 0.08, above company's average Long Term Debt to Equity.

Within Major Pharmaceutical Preparations industry Frequency Therapeutics Inc achieved lowest Long Term Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
Learn more about FREQ
Long Term Debt to Equity Ratio FREQ on the trailing twelve month basis
Long Term Debt to Equity third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Frequency Therapeutics Inc 's Equity $ 82 Millions Visit FREQ's Balance sheet
Frequency Therapeutics Inc 's Long Term Debt $ 7 Millions Visit FREQ's Balance sheet
Source of FREQ's Sales Visit FREQ's Sales by Geography


Cumulative Frequency Therapeutics Inc 's Long Term Debt to Equity

FREQ's Long Term Debt to Equity for the trailling 12 Months

FREQ Long Term Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -44.28 % -42.27 % -36.49 % -32.04 % -26.29 %
Y / Y Long Term Debt TTM Growth -55.55 % -38.89 % -22.22 % -5.55 % -
Long Term Debt to Equity TTM 0.1 0.1 0.1 0.1 0.09
Total Ranking TTM # # # # #
Seq. Equity TTM Growth -14.48 % -14.93 % -13.88 % -11.07 % -11.4 %
Seq. Long Term Debt TTM Growth -27.27 % -21.43 % -17.65 % -5.55 % 0 %


TTM Long Term Debt to Equity Comment
On the trailing twelve months basis Due to long-term debt repayement of -27.27% Frequency Therapeutics Inc has not changed Long Term Debt to Equity in the III. Quarter to 0.1, above Frequency Therapeutics Inc 's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry FREQ recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Long Term Debt to Equity Ratio?
Learn more about FREQ
Long Term Debt to Equity Ratio FREQ on the trailing twelve month basis

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market # 0


TTM Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Long Term Debt to EquitySep 30 2022 MRQ Long Term DebtSep 30 2022 MRQ Equity
Savara Inc   0.22 $ 26.010  Millions$ 116.514  Millions
Arcturus Therapeutics Holdings Inc   0.22 $ 32.038  Millions$ 145.667  Millions
Capricor Therapeutics inc   0.22 $ 3.376  Millions$ 15.426  Millions
Liquidia Corporation  0.21 $ 19.741  Millions$ 95.034  Millions
Cue Biopharma Inc   0.20 $ 9.956  Millions$ 50.764  Millions
Iveric Bio Inc   0.18 $ 47.649  Millions$ 259.526  Millions
Centessa Pharmaceuticals Plc  0.18 $ 68.200  Millions$ 372.921  Millions
United Therapeutics Corporation  0.18 $ 800.000  Millions$ 4,562.200  Millions
Orgenesis Inc   0.17 $ 5.162  Millions$ 30.250  Millions
Lexicon Pharmaceuticals Inc   0.17 $ 23.784  Millions$ 144.018  Millions
Equillium Inc   0.16 $ 4.616  Millions$ 28.160  Millions
Rani Therapeutics Holdings Inc   0.16 $ 14.091  Millions$ 86.607  Millions
Provention Bio Inc   0.16 $ 23.298  Millions$ 144.769  Millions
Hcw Biologics Inc   0.15 $ 6.448  Millions$ 42.555  Millions
Adial Pharmaceuticals Inc   0.15 $ 0.817  Millions$ 5.409  Millions
F star Therapeutics Inc   0.15 $ 8.525  Millions$ 56.938  Millions
Amphastar Pharmaceuticals Inc   0.15 $ 74.011  Millions$ 505.165  Millions
Kempharm Inc  0.14 $ 12.800  Millions$ 93.794  Millions
Vaxxinity Inc   0.12 $ 10.032  Millions$ 80.261  Millions
Aptevo Therapeutics Inc   0.12 $ 1.910  Millions$ 15.762  Millions
Prophase Labs Inc   0.12 $ 7.999  Millions$ 67.921  Millions
Eagle Pharmaceuticals inc   0.11 $ 26.431  Millions$ 231.780  Millions
Bicycle Therapeutics Plc  0.10 $ 30.232  Millions$ 289.474  Millions
Regeneron Pharmaceuticals Inc   0.09 $ 1,981.100  Millions$ 21,438.800  Millions
Longeveron Inc   0.09 $ 2.185  Millions$ 24.615  Millions
Opko Health Inc   0.09 $ 141.815  Millions$ 1,629.068  Millions
89bio Inc   0.08 $ 12.958  Millions$ 152.575  Millions
Frequency Therapeutics Inc   0.08 $ 6.667  Millions$ 81.973  Millions
Viracta Therapeutics Inc   0.07 $ 4.999  Millions$ 67.812  Millions
Vera Therapeutics Inc   0.05 $ 4.966  Millions$ 105.718  Millions

Date modified: 2022-11-10T15:28:51+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NPHC's Profile

Stock Price

NPHC's Financials

Business Description

Fundamentals

Charts & Quotes

NPHC's News

Suppliers

NPHC's Competitors

Customers & Markets

Economic Indicators

NPHC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071